102 related articles for article (PubMed ID: 17979943)
1. Proteomic evaluation of pathways associated with dexamethasone-mediated apoptosis and resistance in multiple myeloma.
Rees-Unwin KS; Craven RA; Davenport E; Hanrahan S; Totty NF; Dring AM; Banks RE; J Morgan G; Davies FE
Br J Haematol; 2007 Nov; 139(4):559-67. PubMed ID: 17979943
[TBL] [Abstract][Full Text] [Related]
2. Triptolide overcomes dexamethasone resistance and enhanced PS-341-induced apoptosis via PI3k/Akt/NF-kappaB pathways in human multiple myeloma cells.
Yang M; Huang J; Pan HZ; Jin J
Int J Mol Med; 2008 Oct; 22(4):489-96. PubMed ID: 18813856
[TBL] [Abstract][Full Text] [Related]
3. PC cell-derived growth factor confers resistance to dexamethasone and promotes tumorigenesis in human multiple myeloma.
Wang W; Hayashi J; Serrero G
Clin Cancer Res; 2006 Jan; 12(1):49-56. PubMed ID: 16397023
[TBL] [Abstract][Full Text] [Related]
4. Bortezomib overcomes cell-adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma.
Noborio-Hatano K; Kikuchi J; Takatoku M; Shimizu R; Wada T; Ueda M; Nobuyoshi M; Oh I; Sato K; Suzuki T; Ozaki K; Mori M; Nagai T; Muroi K; Kano Y; Furukawa Y; Ozawa K
Oncogene; 2009 Jan; 28(2):231-42. PubMed ID: 18850009
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis of the cortisol-mediated stress response in THP-1 monocytes using DIGE technology.
Billing AM; Fack F; Renaut J; Olinger CM; Schote AB; Turner JD; Muller CP
J Mass Spectrom; 2007 Nov; 42(11):1433-44. PubMed ID: 17960574
[TBL] [Abstract][Full Text] [Related]
6. Heat shock protein-90 inhibitors increase MHC class I-related chain A and B ligand expression on multiple myeloma cells and their ability to trigger NK cell degranulation.
Fionda C; Soriani A; Malgarini G; Iannitto ML; Santoni A; Cippitelli M
J Immunol; 2009 Oct; 183(7):4385-94. PubMed ID: 19748980
[TBL] [Abstract][Full Text] [Related]
7. The bone marrow stromal environment is a major factor in myeloma cell resistance to dexamethasone.
Grigorieva I; Thomas X; Epstein J
Exp Hematol; 1998 Jul; 26(7):597-603. PubMed ID: 9657134
[TBL] [Abstract][Full Text] [Related]
8. Dominant negative Rac1 attenuates paclitaxel-induced apoptosis in human melanoma cells through upregulation of heat shock protein 27: a functional proteomic analysis.
Lee SC; Sim N; Clement MV; Yadav SK; Pervaiz S
Proteomics; 2007 Nov; 7(22):4112-22. PubMed ID: 17952876
[TBL] [Abstract][Full Text] [Related]
9. A pivotal role for heat shock protein 90 in Ewing sarcoma resistance to anti-insulin-like growth factor 1 receptor treatment: in vitro and in vivo study.
Martins AS; Ordoñez JL; García-Sánchez A; Herrero D; Sevillano V; Osuna D; Mackintosh C; Caballero G; Otero AP; Poremba C; Madoz-Gúrpide J; de Alava E
Cancer Res; 2008 Aug; 68(15):6260-70. PubMed ID: 18676850
[TBL] [Abstract][Full Text] [Related]
10. Ectopic cyclin D1 overexpression increases chemosensitivity but not cell proliferation in multiple myeloma.
Kuroda Y; Sakai A; Tsuyama N; Katayama Y; Munemasa S; Asaoku H; Okikawa Y; Nakaju N; Mizuno M; Ogawa K; Nishisaka T; Matsui H; Tanaka H; Kimura A
Int J Oncol; 2008 Dec; 33(6):1201-13. PubMed ID: 19020753
[TBL] [Abstract][Full Text] [Related]
11. Regulation of calcineurin activity in insulin-secreting cells: stimulation by Hsp90 during glucocorticoid-induced apoptosis.
Ranta F; Düfer M; Stork B; Wesselborg S; Drews G; Häring HU; Lang F; Ullrich S
Cell Signal; 2008 Oct; 20(10):1780-6. PubMed ID: 18611438
[TBL] [Abstract][Full Text] [Related]
12. Zoledronate has an antitumor effect and induces actin rearrangement in dexamethasone-resistant myeloma cells.
Koizumi M; Nakaseko C; Ohwada C; Takeuchi M; Ozawa S; Shimizu N; Cho R; Nishimura M; Saito Y
Eur J Haematol; 2007 Nov; 79(5):382-91. PubMed ID: 17903213
[TBL] [Abstract][Full Text] [Related]
13. Anti-myeloma activity of the novel 2-aminothienopyrimidine Hsp90 inhibitor NVP-BEP800.
Stühmer T; Chatterjee M; Grella E; Seggewiss R; Langer C; Müller S; Schoepfer J; Garcia-Echeverria C; Quadt C; Jensen MR; Einsele H; Bargou RC
Br J Haematol; 2009 Nov; 147(3):319-27. PubMed ID: 19686236
[TBL] [Abstract][Full Text] [Related]
14. The effect of azacitidine on interleukin-6 signaling and nuclear factor-kappaB activation and its in vitro and in vivo activity against multiple myeloma.
Khong T; Sharkey J; Spencer A
Haematologica; 2008 Jun; 93(6):860-9. PubMed ID: 18443271
[TBL] [Abstract][Full Text] [Related]
15. Intratympanic dexamethasone up-regulates Fkbp5 in the cochleae of mice in vivo.
Maeda Y; Fukushima K; Kariya S; Orita Y; Nishizaki K
Acta Otolaryngol; 2012 Jan; 132(1):4-9. PubMed ID: 22026503
[TBL] [Abstract][Full Text] [Related]
16. Proteomic analysis of multidrug-resistance mechanisms in adriamycin-resistant variants of DLKP, a squamous lung cancer cell line.
Keenan J; Murphy L; Henry M; Meleady P; Clynes M
Proteomics; 2009 Mar; 9(6):1556-66. PubMed ID: 19242932
[TBL] [Abstract][Full Text] [Related]
17. Hsp90-mediated inhibition of FKBP38 regulates apoptosis in neuroblastoma cells.
Erdmann F; Jarczowski F; Weiwad M; Fischer G; Edlich F
FEBS Lett; 2007 Dec; 581(29):5709-14. PubMed ID: 18036348
[TBL] [Abstract][Full Text] [Related]
18. Effect of EPA on Hsp90 and GRα protein expression in multiple myeloma drug-resistant cells.
Wu S; Chen Y; Wang X; Weng S; Zhou W; Liu Z
BMC Cancer; 2021 Oct; 21(1):1076. PubMed ID: 34600510
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis.
Chetoui N; Sylla K; Gagnon-Houde JV; Alcaide-Loridan C; Charron D; Al-Daccak R; Aoudjit F
Mol Cancer Res; 2008 Jan; 6(1):42-52. PubMed ID: 18234961
[TBL] [Abstract][Full Text] [Related]
20. Patients with multiple sclerosis resisted to glucocorticoid therapy: abnormal expression of heat-shock protein 90 in glucocorticoid receptor complex.
Matysiak M; Makosa B; Walczak A; Selmaj K
Mult Scler; 2008 Aug; 14(7):919-26. PubMed ID: 18573821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
